Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)
China · Delayed Price · Currency is CNY 12.17
+0.80 (7.04%)
Jul 10, 2026, 3:06 PM CST
SHE:300122 Market Cap
SHE:300122 has a market cap or net worth of 29.13 billion as of July 10, 2026. Its market cap has decreased by -35.81% in one year.
Market Cap
29.13B
Enterprise Value
38.99B
Revenue
8.75B
Ranking
n/a
PE Ratio
n/a
Stock Price
12.17
Market Cap Chart
Since September 28, 2010, SHE:300122's market cap has increased from 15.42B to 29.13B, an increase of 88.93%. That is a compound annual growth rate of 4.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 29.13B | -35.51% |
| Dec 31, 2025 | 45.17B | -28.25% |
| Dec 31, 2024 | 62.96B | -57.07% |
| Dec 29, 2023 | 146.66B | 4.37% |
| Dec 30, 2022 | 140.53B | -29.51% |
| Dec 31, 2021 | 199.36B | -15.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharmaron Beijing | 52.08B |
| Sunshine Guojian Pharmaceutical (Shanghai) | 47.32B |
| Suzhou Zelgen Biopharmaceuticals | 36.23B |
| Beijing Wantai Biological Pharmacy Enterprise | 35.21B |
| Shanghai RAAS Blood Products | 29.37B |
| Beijing Tiantan Biological Products | 23.89B |
| Hualan Biological Engineering | 23.39B |
| Xiamen Amoytop Biotech | 22.74B |